Agios Pharmaceuticals Inc... (AGIO)
33.19
-0.13 (-0.39%)
At close: Jan 15, 2025, 12:24 PM
Balance Sheet (Annual)
Get detailed breakdowns of the balance-sheet with total debts, total investments, and much more.
| Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 | FY12 | FY11 |
| Cash & Equivalents | 88.20M | 139.26M | 203.13M | 127.44M | 80.93M | 805.42M | 567.75M | 573.56M | 375.91M | 14.03M | 71.56M | 91.30M | 117.66M |
| Short-Term Investments | 688.72M | 643.86M | 816.89M | 445.49M | 483.95M | 514.80M | 321.21M | 380.56M | 245.24M | 328.03M | 95.21M | 36.68M | 61.51M |
| Long-Term Investments | 29.43M | 313.87M | 266.38M | 97.61M | 152.93M | 220.12M | 143.81M | 32.25M | 58.91M | 125.38M | 27.13M | n/a | n/a |
| Other Long-Term Assets | 4.06M | 3.96M | 2.90M | 1.13M | -279.04M | 238.00K | 891.00K | 1.61M | 611.00K | 590.00K | 575.00K | 593.00K | 626.00K |
| Receivables | 2.81M | 2.21M | 4.38M | n/a | 15.32M | 10.44M | 3.67M | 8.31M | 11.60M | 12.67M | 476.00K | n/a | n/a |
| Inventory | 19.08M | 8.49M | 16.19M | 14.70M | 7.33M | 869.00K | -143.81M | -32.25M | -58.91M | 1.00 | n/a | n/a | n/a |
| Other Current Assets | 35.02M | 38.95M | 39.84M | 49.05M | 24.18M | 34.33M | 17.66M | 10.26M | 8.73M | 4.81M | 5.00M | 3.09M | 11.42M |
| Total Current Assets | 833.84M | 832.77M | 1.06B | 636.68M | 611.70M | 613.78M | 445.26M | 559.89M | 337.33M | 359.55M | 169.75M | 130.14M | 190.59M |
| Property-Plant & Equipment | 69.79M | 88.12M | 104.23M | 117.54M | 126.11M | 24.32M | 24.43M | 25.34M | 23.22M | 6.39M | 3.76M | 3.56M | 3.22M |
| Goodwill & Intangibles | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Total Long-Term Assets | 103.28M | 405.95M | 373.50M | 216.28M | 279.04M | 244.68M | 169.14M | 59.20M | 82.74M | 132.36M | 31.46M | 6.86M | 3.88M |
| Total Assets | 937.12M | 1.24B | 1.44B | 852.95M | 890.74M | 858.46M | 614.40M | 619.09M | 420.06M | 491.90M | 201.21M | 137.01M | 194.47M |
| Account Payables | 9.78M | 18.62M | 16.70M | 17.72M | 21.90M | 17.88M | 22.77M | 17.11M | 14.75M | 11.07M | 3.68M | 3.31M | 3.57M |
| Deferred Revenue | n/a | n/a | n/a | n/a | 10.93M | 92.52M | 163.64M | 190.21M | 24.36M | 35.69M | 25.07M | 25.07M | 25.07M |
| Short-Term Debt | 15.01M | 13.66M | 11.16M | 14.82M | 13.83M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Other Current Liabilities | 43.17M | 30.35M | 31.97M | 61.85M | 46.23M | 42.91M | 34.33M | 35.41M | 18.48M | 10.49M | 6.72M | 1.77M | 1.60M |
| Total Current Liabilities | 67.95M | 62.63M | 59.83M | 94.39M | 92.89M | 93.50M | 94.94M | 88.43M | 52.89M | 61.09M | 36.93M | 35.11M | 48.16M |
| Long-Term Debt | 56.99M | 72.00M | 85.94M | 195.58M | 213.49M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Other Long-Term Liabilities | 1.16M | 3.28M | n/a | 163.48M | -106.75M | 17.61M | 18.16M | 17.77M | 17.36M | 3.72M | 226.00K | 15.00K | 33.00K |
| Total Long-Term Liabilities | 58.14M | 75.28M | 85.94M | 359.06M | 157.33M | 77.42M | 143.95M | 172.07M | 22.06M | 6.45M | 32.79M | 58.00M | 83.17M |
| Total Liabilities | 126.10M | 137.90M | 145.76M | 453.45M | 250.21M | 170.92M | 238.89M | 260.50M | 74.95M | 67.54M | 69.72M | 93.11M | 131.33M |
| Total Debt | 72.00M | 85.66M | 97.09M | 105.20M | 113.66M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Common Stock | 72.00K | 71.00K | 71.00K | 69.00K | 68.00K | 58.00K | 49.00K | 42.00K | 38.00K | 37.00K | 31.00K | 3.00K | 3.00K |
| Retained Earnings | -822.65M | -470.56M | -238.76M | -1.84B | -1.52B | -1.10B | -798.06M | -483.15M | -284.68M | -166.95M | -113.44M | -74.04M | -53.94M |
| Comprehensive Income | -441.00K | -12.54M | -1.20M | 105.00K | 202.00K | -2.17M | -1.39M | -313.00K | -318.00K | -57.00K | 14.00K | -2.00K | 23.00K |
| Shareholders Equity | 811.02M | 1.10B | 1.29B | 399.50M | 640.53M | 687.54M | 375.50M | 358.59M | 345.12M | 424.37M | 131.48M | 43.90M | 63.14M |
| Total Investments | 718.16M | 957.73M | 1.08B | 543.10M | 636.88M | 734.92M | 465.03M | 412.81M | 304.14M | 453.42M | 122.33M | 36.68M | 61.51M |